Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions
about
Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative ReviewGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesThe Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesRXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.Pityriasis Lichenoides-like Mycosis Fungoides: Clinical and Histologic Features and Response to Phototherapy.Mycosis fungoides patient accompanied actinic keratosis, actinic keratosis with squamous cell carcinoma transformation, and porokeratosis after NBUVB therapy - 1st case report and review of the literatureMycosis fungoides mimicking tinea pedis.Mycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene.Skin cancer in kidney transplant recipients.New and established treatment options for mycosis fungoides and Sézary syndrome - an update.Cyclophosphamide in dermatology.Curcumin and hydroxamate-derivative (PCI-34058) interfere with histone deacetylase I catalytic core Asp-His charge relay system: atomistic simulation studies.Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma.NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients.Cutaneous T-cell lymphoma with nasal necrosis.DMF: a promising therapeutic option in CTCL.Alemtuzumab in refractory Sézary syndrome.Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis.AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study.Hypopigmented mycosis fungoides: a 20-case retrospective series.Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.Monoclonal antibodies against cutaneous T-cell lymphomas.Prognostic indicators for mycosis fungoides in a Greek population.Long-term remission of erythrodermic mycosis fungoides after persistent control of hepatitis B infection.[Treatment of mycosis fungoides and Sézary syndrome].The efficacy and safety of phototherapy in geriatric patients: a retrospective study.Extracorporeal Photopheresis-An OverviewEvaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoidesExtensive Cutaneous T-Cell Lymphoma of the Feet Treated with High-Dose-Rate Brachytherapy and External Beam Radiation
P2860
Q28075343-BC6E25CF-8D77-4D79-9430-047D512C9BFEQ30276550-E6149004-5C41-46BA-8EC5-37A6095AC9DAQ34545956-42C20B62-5C2D-4CDD-88B3-CFDB736CCF36Q34785645-26C3FDF0-87D7-4EB7-8A9F-D9AD9B3FBF4BQ35669880-40257428-4C1A-4E97-A8DB-4F3963DC2C06Q35689166-370CD890-A342-4BF2-BCEA-77562C077783Q35752062-199016F3-104B-4B0A-9004-1959927BF56DQ35995939-54ABB86F-3920-4D90-8605-8B35B14B0C19Q36187589-608A2B35-3F05-4CB4-B8AF-1AE859ED2056Q36774123-46FF3607-865E-49D8-9E10-2E41A3790002Q37339353-A3D8B945-474A-4C8B-8666-04819DF6A4EFQ37354775-5E6A825B-F8FE-4AF9-8752-DFDF0D87CD3AQ37470053-24EC0209-05E7-4D32-B212-16C8426E4429Q37542591-FCCAD4B0-DE84-47B4-B3A6-68DC569A1F6DQ38210273-76851D29-7A92-4E57-9DD1-7D9F221930ACQ38216976-05B10362-999B-4CA6-9166-45F7155FB1D5Q38710150-DE8F9225-1D32-483C-89DE-297593769D9DQ39019571-D48A47B2-FFE4-4318-8AA7-10FBB179DF4BQ39557726-15DCD660-ABFF-43E5-9BE7-915C8431FD6FQ40131573-18F4BC62-F22F-4CF9-BEE8-123BAA6FBEAFQ41233629-A2B6EBDD-E5DA-4330-A7D4-5FD5A7F6C7C1Q41254403-9A25D145-4FF2-4C80-8F27-E6A76F691022Q42105415-FF89B17F-8D83-4D6E-85BA-32BA15CF14DAQ42361264-6E199857-4514-4CCD-89B3-4F83C8FAB484Q42377651-090CB4AC-9937-4A3A-93F1-898FE5030E58Q47100819-1368F4E5-B315-48D8-BB1B-1D283BA08923Q47177541-BEB5AE89-2AF9-45F4-90CE-565AE216B499Q47836540-7EAC97EB-3AB1-4E62-B85B-C8A0B022E513Q48167908-CA774445-9372-4B99-982B-186E918243BCQ48273894-F2490D80-3F31-401F-9330-120FE5428951Q50938874-8E67BE52-8995-467B-B439-03C772349DF9Q51803389-542DF960-50C8-45FC-A2E1-CD783637E915Q53039521-6110A767-79A4-4C44-B34A-66181107E2EFQ53065632-44BE0B5F-10C7-4465-BD73-0E5B7C5BB0AEQ53128681-8417EADE-291B-4154-8208-9FFC48CB911EQ54940352-E2573AB3-843F-4176-B10A-E332F385C388Q57167371-FF934854-F357-42D4-88C7-C079C88559F5Q58777674-5FA6B6ED-4DF5-4C07-8589-DBC8DD11F15BQ58797009-12025670-9E5F-423F-980D-1AF625732B7B
P2860
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Primary cutaneous T-cell lymph ...... agement, and future directions
@ast
Primary cutaneous T-cell lymph ...... agement, and future directions
@en
Primary cutaneous T-cell lymph ...... agement, and future directions
@nl
type
label
Primary cutaneous T-cell lymph ...... agement, and future directions
@ast
Primary cutaneous T-cell lymph ...... agement, and future directions
@en
Primary cutaneous T-cell lymph ...... agement, and future directions
@nl
prefLabel
Primary cutaneous T-cell lymph ...... agement, and future directions
@ast
Primary cutaneous T-cell lymph ...... agement, and future directions
@en
Primary cutaneous T-cell lymph ...... agement, and future directions
@nl
P2093
P3181
P1476
Primary cutaneous T-cell lymph ...... agement, and future directions
@en
P2093
Alison Moskowitz
Christiane Querfeld
Patricia L Myskowski
Sarah I Jawed
Steven Horwitz
P304
223.e1-17; quiz 240-2
P3181
P356
10.1016/J.JAAD.2013.08.033
P407
P577
2014-02-01T00:00:00Z